Showing 1041-1050 of 21419 results for "".
- IMPACC Links Acute COVID-19 to Viral Reactivationhttps://reachmd.com/news/impacc-acute-covid-19-viral-reactivation/2488625/Key Takeaways Among hospitalized patients with COVID-19, acute illness was accompanied by significant Herpesviridae and Anelloviridae reactivation. Viral reactivation correlated with disease severity, host immune effects, and clinical outcomes in th
- Atopic Dermatitis Linked to Higher Incident Psoriasis Riskhttps://reachmd.com/news/atopic-dermatitis-linked-to-higher-incident-psoriasis-risk/2488618/Key Takeaways In a US electronic health record cohort, atopic dermatitis was associated with significantly higher incident psoriasis risk than in matched controls without atopic dermatitis. Among systemically treated patients, biologics were associated with lower pso
- Tele-ID at Community Hospital: Outcomes Unchanged, Imaging Higherhttps://reachmd.com/news/tele-id-at-community-hospital-outcomes-unchanged-imaging-higher/2488615/Key Takeaways Among patients receiving ID consultations at the community hospital that switched to telehealth, 30-day readmission was 17.4% before versus 17.7% during tele-ID, and mortality was 9.2% versus 8.7%; neither difference was statistically significant. Adjus
- Short-Course Vunakizumab Shows Rapid Improvement in Pediatric GPPhttps://reachmd.com/news/short-course-vunakizumab-shows-rapid-improvement-in-pediatric-generalized-pustular-psoriasis/2488622/Short-course treatment with vunakizumab was temporally associated with rapid improvement of acute generalized pustular psoriasis (GPP) flares in 3 pediatric patients, according to a case series published in Frontiers in Immunology. Vunakizumab Treatment in Pediatric GPP Flares
- 2-Year Icotrokinra Data Show Sustained Clearance in High-Impact Psoriasis Siteshttps://reachmd.com/news/2-year-icotrokinra-data-show-sustained-clearance-in-high-impact-psoriasis-sites/2488612/Johnson & Johnson reported 2-year Phase 3 data showing sustained skin clearance with icotrokinra in adults and adolescents aged 12 years or older with plaque psoriasis involving high-impact sites. The late-breaking ICONIC-TOTAL results were presented at the Europ
- Infant Skin Microbiome Patterns Differ by Atopic Phenotypehttps://reachmd.com/news/infant-skin-microbiome-patterns-atopic-phenotype/2488599/Key Takeaways In the VITALITY infant cohort, distinct skin microbiome signatures were reported across atopic phenotypes rather than a single shared profile. No taxa distinguished infants with food allergy alone or food sensitizati
- Investigating BMI at Pediatric IBD Diagnosishttps://reachmd.com/news/bmi-pediatric-ibd-diagnosis/2488605/Key Takeaways Among children newly diagnosed with IBD at two pediatric referral centers, 23% were underweight, 68% had normal BMI, and 9% were overweight at diagnosis. Growth failure was observed in 7% at diagnosis and 5.3% at 36 months. Underweight was more
- Lebrikizumab Improves Hand and Foot AD in Phase 3b ADtouch Trialhttps://reachmd.com/news/lebrikizumab-improves-hand-and-foot-ad-in-phase-3b-adtouch-trial/2488591/Lebrikizumab-lbkz (Ebglyss; Eli Lilly and Company) improved skin clearance, itch, and pain compared with placebo among adults and adolescents with moderate-to-severe atopic dermatitis (AD) affecting the hands and feet, according to Phase 3b ADtouch results presented at the
- UCB to Present Myasthenia Gravis Data, Including Early Cizutamig Results, at AANEM 2026https://reachmd.com/news/ucb-to-present-myasthenia-gravis-data-including-early-cizutamig-results-at-aanem-2026/2488579/Key Takeaways UCB is presenting data from its generalized myasthenia gravis (gMG) portfolio at the AANEM Annual Meeting and the Myasthenia Gravis Foundation of America (MGFA) Scientific Session, September 29 to October 2 in Orlando, Florida.
- Anti-CXCR3 IgG Linked to Carotid Atherosclerosis in RAhttps://reachmd.com/news/anti-cxcr3-igg-linked-to-carotid-atherosclerosis-in-ra/2488577/Key Takeaways Anti-CXCR3 IgG levels were lower in early and established rheumatoid arthritis, clinically suspect arthralgia, and Sjögren disease than in their respective healthy-control groups. Lower antibody levels were associated with carotid plaque in early RA aft